Hold Cipla; target of Rs 510: Edelweiss

Trade

• Watchlist
• Portfolio
• Message
• Set Alert

 

 

Choose Stock Exchange: BSE LIVE NSE LIVE

26 Aug, 2025 12:21

Volume

Todays L/H

More

×

Edelweiss' research report on Cipla

Cipla’s Q4FY17 revenue grew mere 7% YoY due to dip in India and emerging markets. US business was flat through FY17 despite 18 launches. EBITDA margin plummeted to 14% due to higher R&D (8.6% of sales), which is expected to remain elevated. Adjusted for INR 2.7bn one-off, net profit came at INR 2bn compared to INR 3bn estimate.

Outlook

Given that some of Cipla’s most important investments in the past 3 years continue to face structural pressures—US (competitive pressure & price erosion) and emerging markets (forex volatility, price decline in Middle East, rising competition)—its organic growth trajectory may not pan out to full potential. We maintain ‘HOLD/SP’ with target price of INR 510.

For all recommendations, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Read More